<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00186758</url>
  </required_header>
  <id_info>
    <org_study_id>TMS2092</org_study_id>
    <nct_id>NCT00186758</nct_id>
  </id_info>
  <brief_title>Transcranial Magnetic Stimulation in Bipolar Depression</brief_title>
  <acronym>TMS</acronym>
  <official_title>A Randomized, Sham Controlled, Crossover Trial of rTMS for Bipolar Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Joseph's Healthcare Hamilton</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Queen's University, Kingston, Ontario</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>St. Joseph's Healthcare Hamilton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare antidepressant efficacy of left or right to sham Repetitive Transcranial Magnetic
      Stimulation (rTMS)

      to determine if non-responders can become responders if treated on the other side of the
      hemisphere

      (rTMS)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be assigned to one of 3 treatment arms for 10 days of treatment with either
      left high frequency or right high frequency, or sham rTMS. After 10 days of treatment, and no
      improvement, another 10 days of treatment follows, this time with the coil placed on the
      other hemisphere. Subjects will be followed for 2 months respectively with unrestricted
      treatment provided by their regular physician. Mood stabilizers will be continued throughout
      this trial.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2002</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare antidepressant efficacy of right, left to sham</measure>
    <time_frame>within 9 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine if QEEG activity correlates with antidepressant response to rTMS</measure>
    <time_frame>within 9 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To determine if non-responders can become responders if treating the opposite hemisphere</measure>
    <time_frame>within 9 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bipolar Affective Disorder</condition>
  <arm_group>
    <arm_group_label>1, Phase l, True or Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>this treatment will be True or Sham (placebo) on one side of the head, phase I</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2, phase ll, Sham or True</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This treatment will be Sham(placebo)or True on the other side of the head phase II.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Magnetic Stimulation (TMS)</intervention_name>
    <description>Phase l clients receive either True or Sham TMS treatments on left or right side of head for 10 days.
Phase ll clients will receive either Sham or True TMS treatments on the other side of the head - the same type as in phase l -</description>
    <arm_group_label>1, Phase l, True or Sham</arm_group_label>
    <arm_group_label>2, phase ll, Sham or True</arm_group_label>
    <other_name>HamD</other_name>
    <other_name>BDI II</other_name>
    <other_name>VAS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Bipolar Depression

          -  no physical health problems

        Exclusion Criteria:

          -  Metal in head/neck or skull

          -  History of Epilepsy

          -  Pregnancy

          -  Pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary Hasey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McMaster University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. Joseph's Healthcare, rTMS Laboratory, Mood Disorder Program, 100 West Fifth Street</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3K7</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2005</study_first_posted>
  <last_update_submitted>August 2, 2011</last_update_submitted>
  <last_update_submitted_qc>August 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Gary Hasey, Director, TMS Laboratory</name_title>
    <organization>McMaster University</organization>
  </responsible_party>
  <keyword>Transcranial Magnetic Stimulation</keyword>
  <keyword>TMS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
    <mesh_term>Mood Disorders</mesh_term>
    <mesh_term>Genetic Diseases, X-Linked</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

